We are live on
!
Find out more
BE
Bonness Enterprises Portfolio holdings
AUM
$310M
1-Year Est. Return
24.22%
This Fund
S&P 500
This Quarter
Est. Return
+15.05%
1 Year Est. Return
+24.22%
3 Year Est. Return
+94.56%
5 Year Est. Return
+137.52%
10 Year Est. Return
+441.57%
AUM
$154M
AUM Growth
+$20.9M
(+16%)
Cap. Flow
+$1.22M
Cap. Flow
% of AUM
0.79%
Top 10 Holdings %
Top 10 Hldgs %
61.67%
Holding
44
New
1
Increased
3
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CAJ
Canon, Inc.
CAJ
|
+$936K |
| 2 |
BT
BT Group plc (ADR)
BT
|
+$664K |
| 3 |
T
A T & T CORP (NEW)
T
|
+$195K |
| 4 |
GSK
GSK
|
+$8K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$72K |
| 2 |
GE Aerospace
GE
|
+$41.8K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 32.59% |
| 2 | Healthcare | 27.56% |
| 3 | Technology | 20.71% |
| 4 | Industrials | 4.83% |
| 5 | Consumer Staples | 4.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Progressive
PGR
$122B
| $43.7M | 28.36% |
605,608
| – | – |
|
|
2
Stryker
SYK
$131B
| $13.9M | 9.06% |
70,600
-400
| -0.6% | -$72K |
|
3
Microsoft
MSFT
$3.62T
| $6.69M | 4.34% |
56,700
| – | – |
|
4
Johnson & Johnson
JNJ
$613B
| $5.46M | 3.54% |
39,038
| – | – |
|
5
Intel
INTC
$459B
| $4.83M | 3.14% |
89,950
| – | – |
|
6
Cisco
CSCO
$457B
| $4.3M | 2.79% |
79,700
| – | – |
|
7
IBM
IBM
$213B
| $4.16M | 2.7% |
30,819
| – | – |
|
8
Unilever
UL
$137B
| $4.05M | 2.63% |
62,436
| – | – |
|
9
Merck
MRK
$315B
| $3.94M | 2.56% |
49,675
| – | – |
|
10
DuPont de Nemours
DD
$19.1B
| $3.92M | 2.54% |
29,013
| – | – |
|
11
Pfizer
PFE
$143B
| $3.34M | 2.17% |
82,853
| – | – |
|
12
Thermo Fisher Scientific
TMO
$213B
| $3.15M | 2.04% |
11,500
| – | – |
|
13
Emerson Electric
EMR
$86.7B
| $2.98M | 1.93% |
43,500
| – | – |
|
14
AbbVie
ABBV
$433B
| $2.95M | 1.92% |
36,600
| – | – |
|
15
Nucor
NUE
$59.5B
| $2.76M | 1.79% |
47,350
| – | – |
|
16
Abbott
ABT
$185B
| $2.62M | 1.7% |
32,700
| – | – |
|
17
Apple
AAPL
$4.45T
| $2.61M | 1.69% |
54,940
| – | – |
|
18
Bristol-Myers Squibb
BMY
$134B
| $2.53M | 1.65% |
53,100
| – | – |
|
|
MRSH
19
Marsh
MRSH
$92B
| $2.42M | 1.57% |
25,800
| – | – |
|
20
Verizon
VZ
$198B
| $2.18M | 1.42% |
36,887
| – | – |
|
21
Berkshire Hathaway Class B
BRK.B
$1.11T
| $1.96M | 1.27% |
9,750
| – | – |
|
22
Applied Materials
AMAT
$411B
| $1.94M | 1.26% |
49,000
| – | – |
|
23
Corning
GLW
$126B
| $1.85M | 1.2% |
56,000
| – | – |
|
24
Philips
PHG
$25.6B
| $1.81M | 1.18% |
57,227
| – | – |
|
25
Procter & Gamble
PG
$338B
| $1.71M | 1.11% |
16,400
| – | – |
|
Similar funds
IPW
TL
RGC
IR
TWM
PH
CCG
FI
Bonness Enterprises's Q1 2019 Portfolio in Review
As of Q1 2019, Bonness Enterprises held 44 positions worth $154M, up 16% from $133M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Trading was light in Q1 2019: portfolio turnover was 2.3%. Bonness Enterprises opened 1 new position and made no exits, leaving the 44-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Technology.
- Bonness Enterprises's largest Q1 2019 buy was Canon, Inc.: 32,700 shares worth $950K.
- Bonness Enterprises added most to BT Group plc (ADR) in Q1 2019, an estimated $664K increase.
- Bonness Enterprises's biggest Q1 2019 reduction was Stryker, cutting an estimated $72K.
- Bonness Enterprises's ten largest holdings make up 62% of its $154M portfolio in Q1 2019.
- Bonness Enterprises opened 1 new position and closed 0 in Q1 2019.
- Bonness Enterprises's portfolio value rose 16% quarter-over-quarter to $154M.
Based on Bonness Enterprises's 13F filing for Q1 2019, filed 12 Apr 2019.